CLX Stock Recent News

New contract expands product solutions available to Vizient's diverse customer base PLEASANTON, Calif. , May 8, 2025 /PRNewswire/ -- Clorox Professional (CloroxPro), the trusted makers of a broad portfolio of healthcare and commercial cleaning solutions, is proud to announce our new contract with Vizient, the nation's largest provider-driven healthcare performance improvement company.

Clorox (CLX -2.46%) stock lost ground in Tuesday's trading following the company's recent quarterly report. The company's share price closed out the day down 2.4% and had been down as much as 6.3% earlier in the session.

CLX's Q3 results show strong core fundamentals, market share stability, and gross margin expansion despite economic headwinds and shifting shopping habits.

Both Meta and Microsoft reported after-the-bell on Wednesday, blowing past analyst estimates. With 72% of the S&P 500 having reported for Q1 at this point, the blended EPS growth rate stands at 12.8%, above the 10.1% reading from last week. Eight companies within the S&P 500 confirmed outlier earnings dates for this week, all of which are later than usual and therefore have negative DateBreaks Factors.

Shares of household cleaning name Clorox Co (NYSE:CLX) are down 2.5% at $134.96 at last glance, after the company's fiscal third-quarter earnings and revenue missed estimates.

Clorox Company CLX posted weaker-than-expected third-quarter results after Monday's closing bell.

The Clorox Company (NYSE:CLX ) Q3 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Lisah Burhan - VP, IR Linda Rendle - Chair and CEO Luc Bellet - CFO Conference Call Participants Dara Mohsenian - Morgan Stanley Filippo Falorni - Citi Peter Grom - UBS Anna Lizzul - Bank of America Bonnie Herzog - Goldman Sachs Robert Moskow - TD Cowen Kaumil Gajrawala - Jefferies Javier Escalante - Evercore ISI Andrea Teixeira - JPMorgan Kevin Grundy - BNP Paribas Olivia Tong - Raymond James Chris Carey - Wells Fargo Steve Powers - Deutsche Bank Operator Good day, ladies and gentlemen, and welcome to The Clorox Company Third Quarter Fiscal Year 2025 Earnings Release Conference Call. At this time, all participants are in a listen-only mode.

The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clorox (CLX) came out with quarterly earnings of $1.45 per share, missing the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.71 per share a year ago.

Clorox Co. dials down expectations for 2025 sales, saying that economic uncertainty is leading some people to change their shopping.